All Pharma News
QurAlis to Present Data Showing Link Between TDP-43 Pathology and Role of UNC13A

QurAlis to Present Data Showing Link Between TDP-43 Pathology and Role of UNC13A
PR NEWSWIRE
06 Sep 2023
Share Share
QurAlis, Unlearn link to use machine learning in ALS research

QurAlis, Unlearn link to use machine learning in ALS research
Joseph Keenan FIERCE BIOTECH
28 Jun 2023
Share Share
QurAlis` FlexASOs Show High Potency and Improved Safety Over Standard ASOs

QurAlis` FlexASOs Show High Potency and Improved Safety Over Standard ASOs
PR NEWSWIRE
08 Jun 2023
Share Share
QurAlis receives authorisation to initiate ALS therapy trial in EU

QurAlis receives authorisation to initiate ALS therapy trial in EU
CLINICAL TRIALS ARENA
07 Jun 2023
Share Share
QurAlis Receives CTA in EU for QRL-201

QurAlis Receives CTA in EU for QRL-201
PR NEWSWIRE
06 Jun 2023
Share Share
QurAlis to Participate in Upcoming Investor Conferences in June

QurAlis to Participate in Upcoming Investor Conferences in June
PR NEWSWIRE
01 Jun 2023
Share Share
QurAlis enters ALS space with precision therapy approach

QurAlis enters ALS space with precision therapy approach
CLINICAL TRIALS ARENA
07 Apr 2023
Share Share
QurAlis Reveals Program Targeting UNC13A RNA Incorporating its FlexASO Platform

QurAlis Reveals Program Targeting UNC13A RNA Incorporating its FlexASO Platform
PR NEWSWIRE
20 Mar 2023
Share Share
QurAlis Closes $88M Series B Financing to Advance Precision Medicines

QurAlis Closes $88M Series B Financing to Advance Precision Medicines
PR NEWSWIRE
09 Mar 2023
Share Share
ALS biotech QurAlis gets $88M boost from four pharmas for pair of PhI studies

ALS biotech QurAlis gets $88M boost from four pharmas for pair of PhI studies
Kyle LaHucik ENDPTS
09 Mar 2023
Share Share